Christina Blevins
About Christina Blevins
Christina Blevins is a Senior Clinical Research Associate at DURECT Corporation in Cupertino, California, where she has worked since 2007. She has contributed to research on Larsucosterol treatment for alcohol-associated hepatitis, co-authoring both a presentation and a publication in The American Journal of Gastroenterology.
Work at DURECT Corporation
Christina Blevins has been employed at DURECT Corporation since 2007, serving as a Senior Clinical Research Associate. In this role, she has contributed to various clinical trials and research initiatives, focusing on the evaluation of new treatments. DURECT Corporation is based in Cupertino, California, and specializes in developing innovative therapeutics for chronic diseases.
Education and Expertise
Christina Blevins studied at the University of California, Santa Barbara. Her educational background has equipped her with the necessary knowledge and skills to excel in clinical research. She has developed expertise in evaluating the safety and efficacy of pharmaceutical treatments, particularly in the area of gastroenterology.
Background in Clinical Research
With over 17 years of experience in clinical research, Christina Blevins has a strong background in conducting and overseeing clinical trials. Her work includes co-authoring significant research presentations and publications, contributing to the understanding of treatment options in gastroenterology.
Research Contributions
Christina Blevins co-authored a presentation at the SCSG GI Symposium, focusing on a Phase 2b trial that evaluated the safety and efficacy of Larsucosterol treatment for alcohol-associated hepatitis. Additionally, she co-authored a publication in The American Journal of Gastroenterology, which discussed the safety, pharmacokinetics, and efficacy signals of Larsucosterol in the same context.